16-Tigloyl linked barrigenol-like triterpenoid from Semen Aesculi and its anti-tumor activity in vivo and in vitro-Reference-Cited by-同舟云学术

16-Tigloyl linked barrigenol-like triterpenoid from Semen Aesculi and its anti-tumor activity in vivo and in vitro

Published:2019 Issue:54 Volume:9 Page:31758-31772
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Yang Yiren¹²³⁴,Long Liping¹²³⁴,Zhang Xinxin¹²³⁴,Song Kairu¹²³⁴,Wang Da⁵²⁶⁴,Xiong Xin¹²³⁴,Gao Huiyuan¹²³⁴^ORCID,Sha Luping⁷²³⁴

Affiliation:

1. School of Traditional Chinese Materia Medica

2. Shenyang Pharmaceutical University

3. Benxi 117004

4. People's Republic of China

5. School of Pharmacy

6. Shenyang 110016

7. School of Pharmaceutical Engineering

Abstract

Barrigenol-like triterpenoids (BATs) showed promising anti-tumor, anti-inflammatory and anti-Alzheimer's activities, while, the inhibitory strength was usually affected by their states with aglycones or glycosides.

Funder

Program for Liaoning Innovative Talents in University

State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/RA/C9RA06015D

Reference31 articles.

1. Back to basics: how natural products can provide the basis for new therapeutics

2. Molecular targets and anti-cancer potential of escin

3. Natural barrigenol–like triterpenoids: A comprehensive review of their contributions to medicinal chemistry

4. Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Anti-Inflammatory Constituents from Aesculus wilsonii Seeds;Molecules;2024-03-03

2. Nitrogenous compounds from Aesculus wilsonii seeds;Fitoterapia;2024-01

3. Saponins from Aesculus wilsonii seeds exert anti-inflammatory activity through the suppression of NF-κB and NLRP3 pathway;Arabian Journal of Chemistry;2023-09

4. AHR, a novel inhibitory immune checkpoint receptor, is a potential therapeutic target for chemoresistant glioblastoma;Journal of Cancer Research and Clinical Oncology;2023-05-26

5. Escin’s Multifaceted Therapeutic Profile in Treatment and Post-Treatment of Various Cancers: A Comprehensive Review;Biomolecules;2023-02-07